ปัจจัยส่งเสริมการเกิดโรคติดเชื้ออุบัติใหม่และโรคโควิด-19
คำสำคัญ:
โรคติดเชื้ออุบัติใหม่, โรคโควิด-19, ปัจจัยสนับสนุนการเกิดโรค, โคโรน่าไวรัสสายพันธุ์ซาร์สโควีทบทคัดย่อ
โรคติดเชื้ออุบัติใหม่เป็นปัญหาสำคัญที่ส่งผลกระทบโดยตรงต่อทั้งสุขภาพของประชาชน ระบบสาธารณสุข เศรษฐกิจและความมั่นคงระดับชาติ การอุบัติขึ้นใหม่ของโรคโควิด-19 ซึ่งกำลังระบาดอยู่ในขณะนี้ นอกจากส่งผลให้มีผู้ติดเชื้อและผู้เสียชีวิตเป็นจำนวนมากแล้ว ยังก่อให้เกิดความตื่นตระหนกต่อสถานการณ์ การระบาดไปทั่วโลก การทำให้เกิดความเข้าใจในข้อมูลเกี่ยวกับสาเหตุหรือปัจจัยที่ทำให้เกิดโรคอุบัติใหม่ จึงเป็นสิ่งสำคัญและเป็นพื้นฐานของการวางแผนมาตรการควบคุมโรคที่กำลังแพร่ระบาด รวมทั้งมาตรการป้องกัน การเกิดโรคอุบัติขึ้นใหม่ในอนาคต บทความวิชาการนี้นำเสนอข้อมูลเกี่ยวกับโรคติดเชื้ออุบัติใหม่ โดยเน้นปัจจัย ที่ส่งเสริมให้เกิดการอุบัติขึ้นของโรค พร้อมยกตัวอย่างโรคติดเชื้ออุบัติใหม่ที่เกิดขึ้นภายในคริสต์ศตวรรษที่ 21 โดยได้จัดปัจจัยเหล่านั้นเป็น 4 กลุ่ม ได้แก่ 1) ปัจจัยที่เกี่ยวข้องกับเชื้อก่อโรค 2) ปัจจัยด้านประชากรและ สังคมศาสตร์ 3) ปัจจัยด้านสิ่งแวดล้อม และ 4) ปัจจัยด้านระบบสาธารณสุข รวมทั้งยังได้วิเคราะห์ถึงปัจจัย ที่เกี่ยวข้องกับการอุบัติขึ้นของโรคโควิด-19
References
1. World Health Organization. A brief guide
to emerging infectious diseases and
zoonoses [Internet] 2014 [cited 2020 May
10]. Available from: https://apps.who.int/
iris/handle/10665/204722.
2. Lenz K, Hybel N. The Black Death. Scand
J Hist 2016;41(1):54-70.
3. World Health Organization. Summary
of probable SARS cases with onset of
illness from 1 November 2002 to 31 July
2003 [Internet] 2003 [cited 2020 April 1].
Available from: https://www.who.int/csr/
sars/country/table2004_04_21/en/.
4. World Health Organization. Cumulative
number of confirmed human cases
for avian influenza A(H5N1) reported
to WHO, 2003-2020 [Internet] 2020
[cited 2020 April 1]. Available from:
https://www.who.int/influenza/human_
animal_interface/2020_01_20_tableH5N1.
pdf?ua=1.
5. World Health Organization. Chikungunya
[Internet] 2017 [cited 2020 April 14].
Available from: https://www.who.int/
en/news-room/fact-sheets/detail/
chikungunya.
6. Kelly H, Peck HA, Laurie KL, et al. The agespecific cumulative incidence of infection
with pandemic influenza H1N1 2009
was similar in various countries prior to
vaccination. PLoS One 2011;6(8):e21828.
doi:10.1371/journal.pone.0021828.
7. World Health Organization. MERS situation
update, January 2020 [Internet] 2020
[cited 2020 April 14]. Available from:
http://www.emro.who.int/pandemicepidemic-diseases/mers-cov/merssituation-update-january-2020.html.
8. World Health Organization. Ebola virus
disease [Internet] 2020 [cited 2020 April
10]. Available from: https://www.who.int/
en/news-room/fact-sheets/detail/ebolavirus-disease.
9. World Health Organization. Zika situation
report [Internet] 2017 [cited 2020 April
14]. Available from: https://www.who.
int/emergencies/zika-virus/situationreport/10-march-2017/en/.
10. Wo r l d o m e t e r s . i n f o . C O V I D - 1 9
Coronavirus pandemic 2020 [Internet]
2020 [cited 2020 June 1]. Available
from: https://www.worldometers.info/
coronavirus/#countries.
11. Morse SS. Factors in the emergence
of infectious diseases. Emerg Infect Dis
1995;1(1):7-15.
12. Woolhouse ME, Gowtage-Sequeria
S. Host range and emerging and
reemerging pathogens. Emerg Infect Dis
2005;11(12):1842-7.
13. Mukherjee S. Emerging infectious diseases:
epidemiological perspective. Indian J
Dermatol 2017;62(5):459-67.
14. Woolhouse M, Scott F, Hudson Z, et al.
Human viruses: discovery and emergence.
Philos Trans R Soc B 2012;367(1604):
2864-71.
15. Colson P, Richet H, Desnues C, et al. Pepper
mild mottle virus, a plant virus associated
with specific immune responses, fever,
abdominal pains, and pruritus in humans.
PLoS One 2010;5(4):e10041. doi: 10.1371/
journal.pone.0010041.
16. Lu R, Zhao X, Li J, et al. Genomic
characterization and epidemiology of
2019 novel coronavirus: implications for
virus origins and receptor binding. Lancet
2020;395(10224):565-74.
17. Enright MC, Robinson DA, Randle G, et al.
The evolutionary history of methicillinresistant Staphylococcus aureus (MRSA).
Proc Natl Acad Sci USA 2002;99(11):
7687-92.
18. Chang S, Sievert DM, Hageman JC, et
al. Infection with vancomycin-resistant
Staphylococcus aureus containing the
vanA resistance gene. N Engl J Med
2003;348(14):1342-7.
19. Peacock SJ, Paterson GK. Mechanisms of
methicillin resistance in Staphylococcus
aureus. Annu Rev Biochem 2015;84:577-601.
20. Gardete S, Tomasz A. Mechanisms of
vancomycin resistance in Staphylococcus
aureus. J Clin Invest 2014;124(7):2836-40.
21. Peck KM, Lauring AS. Complexities of viral
mutation rates. J Virol 2018;92(14):e01031-
17 doi: 10.1128/JVI.01031-17.
22. Garten RJ, Davis CT, Russell CA, et al.
Antigenic and genetic characteristics
of swine-origin 2009 A(H1N1) influenza
viruses circulating in humans. Science
2009;325(5937):197-201.
23. de Silva UC, Tanaka H, Nakamura S,
et al. A comprehensive analysis of
reassortment in influenza A virus. Biol
Open 2012;1(4):385-90.
24. Jean-Baptiste A, Michael EH. Virulence
evolution in emerging infectious diseases.
Evolution 2005;59(7):1406-12.
25. Schuffenecker I, Iteman I, Michault A, et al.
Genome microevolution of chikungunya
viruses causing the Indian Ocean outbreak.
PLoS Med 2006;3(7):e263. doi: 10.1371/
journal.pmed.0030263.
26. Tsetsarkin KA, Vanlandingham DL, McGee
CE, et al. A single mutation in chikungunya
virus affects vector specificity and epidemic
potential. PLoS Pathog 2007;3(12):e201.
doi: 10.1371/journal.ppat.0030201.
27. Hapuarachchi HC, Bandara KB, Sumanadasa
SD, et al. Re-emergence of chikungunya
virus in South-East Asia: virological
evidence from Sri Lanka and Singapore.
J Gen Virol 2010;91(Pt 4):1067-76.
28. Rianthavorn P, Prianantathavorn K,
Wuttirattanakowit N, et al. An outbreak
of chikungunya in southern Thailand
from 2008 to 2009 caused by African
strains with A226V mutation. Int J Infect
Dis 2010;14 Sppl 3:e161-5. doi: 10.1016/j.
ijid.2010.01.001.
29. Park YK, Park Y-S, Na KI, et al. Increased
tuberculosis burden due to demographic
transition in Korea from 2001 to 2010.
Tuberc Respir Dis 2013;74(3):104-10.
30. Davies PDO. Tuberculosis in the elderly.
Drugs Aging 1996;8(6):436-44.
31. Thomas TY, Rajagopalan S. Tuberculosis
and aging: a global health problem. Clin
Infect Dis 2001;33(7):1034-9.
32. Zuber PL, McKenna MT, Binkin NJ, et al.
Long-term risk of tuberculosis among
foreign-born persons in the United States.
JAMA 1997;278(4):304-7.
33. Jones KE, Patel NG, Levy MA, et al. Global
trends in emerging infectious diseases.
Nature 2008;451(7181):990-3.
34. Hui DS. Super-spreading events of
MERS-CoV infection. Lancet 2016;388
(10048):942-3.
35. Shen Z, Ning F, Zhou W, et al.
Superspreading SARS events, Beijing,
2003. Emerg Infect Dis 2004;10(2):256-60.
36. Michienzi SM, Burgos RM, Novak RM.
Mycobacterium conceptionense
pneumonitis in patient with HIV/AIDS.
Emerg Infect Dis 2019;25(10):1986-8.
37. Tobin-D’Angelo M, Oosmanally N,
Wilson SN, et al. Shigella bacteremia,
Georgia, USA, 2002-2012. Emerg Infect Dis
2020;26(1):122-4.
38. Wilson ME. Travel and the emergence
of infectious diseases. Emerg Infect Dis
1995;1(2):39-46.
39. Cherry JD. The chronology of the 2002-
2003 SARS mini pandemic. Paediatr Respir
Rev 2004;5(4):262-9.
40. Tatem AJ, Rogers DJ, Hay SI. Global
transport networks and infectious disease
spread. Adv Parasitol 2006;62:293-343.
41. Wilcox B, Ellis B. Forests and emerging
infectious diseases of humans. Unasylva
2006;57:11-8.
42. Bloomfield LSP, McIntosh TL, Lambin
EF. Habitat fragmentation, livelihood
behaviors, and contact between people
and nonhuman primates in Africa. Landsc
Ecol 2020;35(4):985-1000.
43. Olivero J, Fa JE, Real R, et al. Recent
loss of closed forests is associated with
Ebola virus disease outbreaks. Sci Rep
2017;7(1):14291.
44. Southgate VR. Schistosomiasis in the
Senegal River Basin: before and after
the construction of the dams at Diama,
Senegal and Manantali, Mali and future
prospects. J Helminthol 1997;71(2):
125-32.
45. Steinmann P, Keiser J, Bos R, et al.
Schistosomiasis and water resources
development: systematic review, metaanalysis, and estimates of people at risk.
Lancet Infect Dis 2006;6(7):411-25.
46. Sokolow SH, Jones IJ, Jocque M, et al.
Nearly 400 million people are at higher
risk of schistosomiasis because dams
block the migration of snail-eating river
prawns. Philos T R Soc B 2017;372(1722).
47. Caminade C, Kovats S, Rocklov J, et al.
Impact of climate change on global
malaria distribution. Proc Natl Acad Sci
USA 2014;111(9):3286-91.
48. Chretien JP, Anyamba A, Small J, et al.
Global climate anomalies and potential
infectious disease risks: 2014-2015.
PLoS Curr 2015;7. doi: 10.1371/currents.
outbreaks.95fbc4a8fb4695e049baabfc
2fc8289f.
49. Kovats RS, Bouma MJ, Hajat S, et al. El
Nino and health. Lancet 2003;362(9394):
1481-9.
50. Flahault A, de Castaneda RR, Bolon I.
Climate change and infectious diseases.
Public Health Rev 2016;37:21.
51. Phupat P, Sittisak S, Pimrat K, et al.
Epidemiological and serological study of
re-emerging diphtheria in Dansai District,
Loei Province, Thailand, June to October
2012. OSIR 2015;8(1):13-21.
52. Phadke VK, Bednarczyk RA, Salmon DA,
et al. Association between vaccine refusal
and vaccine-preventable diseases in the
United States: a review of measles and
pertussis. JAMA 2016;315(11):1149-58.
53. Wallin T, Holzschuh E, Kintner C. Notes
from the field: rubella infection in an
unvaccinated pregnant woman - Johnson
County, Kansas, December 2017. MMWR
2018;67(40):1132-3.
54. Akil L, Ahmad HA. The recent outbreaks
and reemergence of poliovirus in war and
conflict-affected areas. Int J Infect Dis
2016;49:40-6.
55. Mac Kenzie WR, Hoxie NJ, Proctor ME, et
al. A massive outbreak in Milwaukee of
cryptosporidium infection transmitted
through the public water supply. N Engl
J Med 1994;331(3):161-7.
56. Frank C, Werber D, Cramer JP, et al.
Epidemic profile of Shiga-toxin-producing
Escherichia coli O104:H4 outbreak in
Germany. N Engl J Med 2011;365(19):
1771-80.
57. Gelting R, Bliss K, Patrick M, et al. Water,
sanitation and hygiene in Haiti: past,
present, and future. Am J Trop Med Hyg
2013;89(4):665-70.
58. Chin CS, Sorenson J, Harris JB, et al. The
origin of the Haitian cholera outbreak
strain. N Engl J Med 2011;364(1):33-42.
59. Relman DA, Loutit JS, Schmidt TM, et al.
The agent of bacillary angiomatosis. An
approach to the identification of
uncultured pathogens. N Engl J Med
1990;323(23):1573-80.
60. Ablashi DV, Eastman HB, Owen CB, et al.
Frequent HHV-6 reactivation in multiple
sclerosis (MS) and chronic fatigue
syndrome (CFS) patients. J Clin Virol
2000;16(3):179-91.
61. Alvarez-Lafuente R, Garcia-Montojo M, De
las Heras V, et al. Clinical parameters and
HHV-6 active replication in relapsingremitting multiple sclerosis patients. J Clin
Virol 2006;37 (Sppl) 1:S24-6.
62. Pierce ES. Could Mycobacterium avium
subspecies paratuberculosis cause
Crohn’s disease, ulcerative colitis and
colorectal cancer? Infect Agents Cancer
2018;13:1.
63. Fashner J, Gitu AC. Diagnosis and treatment
of peptic ulcer disease and Helicobacter
pylori Infection. Am Fam Physician
2015;91(4):236-42.
64. Aslam B, Wang W, Arshad MI, et al.
Antibiotic resistance: a rundown of a
global crisis. Infect Drug Resist
2018;11:1645-58.
65. Manyi-Loh C, Mamphweli S, Meyer E, et
al. Antibiotic use in agriculture and its
consequential resistance in environmental
sources: potential public health
implications. Molecules 2018;23(4):795.
66. Marshall BM, Levy SB. Food animals and
antimicrobials: impacts on human health.
Clin Microbiol Rev 2011;24(4):718-33.
67. Engering A, Hogerwerf L, Slingenbergh J.
Pathogen-host-environment interplay and
disease emergence. Emerg Microbes Infect
2013;2(2):e5. doi: 10.1038/emi.2013.5.
68. Rezza G. Chikungunya is back in Italy:
2007–2017. J Travel Med 2018;25(1). doi:
10.1093/jtm/tay004.
69. Zhu N, Zhang D, Wang W, et al. A novel
coronavirus from patients with pneumonia
in China, 2019. N Engl J Med 2020;382(8):
727-33.
70. Li X, Giorgi EE, Marichannegowda MH, et
al. Emergence of SARS-CoV-2 through
recombination and strong purifying
selection. Sci Adv 2020:e9153. doi:
10.1101/2020.03.20.000885.
71. Zhou H, Chen X, Hu T, et al. A novel bat
coronavirus closely related to SARS-CoV-2
contains natural insertions at the S1/S2
cleavage site of the spike protein. Curr
Biol 2020;30(11):2196-203.
72. Allen T, Murray KA, Zambrana-Torrelio C,
et al. Global hotspots and correlates of
emerging zoonotic diseases. Nat Commun
2017;8(1):1124.
73. Li Q, Guan X, Wu P, et al. Early transmission
dynamics in Wuhan, China, of novel
coronavirus–infected pneumonia. N Engl
J Med 2020;382(13):1199-207.
74. World Health Organization. Modes of
transmission of virus causing COVID-19:
implications of IPC precaution
recommendations [Internet] 2020 [cited
2020 June 2]. Available from: https://
www.who.int/news-room/commentaries/
detail/modes-of-transmission-of-viruscausing-covid-19-implications-for-ipcprecaution-recommendations.
75. Al-Tawfiq JA, Rodriguez-Morales AJ. Superspreading events and contribution to
transmission of MERS, SARS, and COVID-19.
J Hosp Infect 2020;105:111-2.
76. Arons MM, Hatfield KM, Reddy SC, et al.
Presymptomatic SARS-CoV-2 Infections
and transmission in a skilled nursing
facility. N Engl J Med 2020;382(22):
2081-90.
77. Tian S, Hu N, Lou J, et al. Characteristics
of COVID-19 infection in Beijing. J Infect
2020;80(4):401-6.
78. World Health Organization. WHO directorgeneral’s opening remarks at the media
briefing on COVID-19 [Internet] 2020 [cited
2020 June 2]. Available from: https://
www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-atthe-media-briefing-on-covid-19-11-
march-2020.
79. World Health Organization. Strengthening
the health system response to COVID-19:
recommendations for the WHO European
Region [Internet] 2020 [cited 2020 June
2]. Available from: http://www.euro.who.
int/__data/assets/pdf_file/0003/436350/
strengthening-health-system-responseCOVID-19.pdf?ua=1.
to emerging infectious diseases and
zoonoses [Internet] 2014 [cited 2020 May
10]. Available from: https://apps.who.int/
iris/handle/10665/204722.
2. Lenz K, Hybel N. The Black Death. Scand
J Hist 2016;41(1):54-70.
3. World Health Organization. Summary
of probable SARS cases with onset of
illness from 1 November 2002 to 31 July
2003 [Internet] 2003 [cited 2020 April 1].
Available from: https://www.who.int/csr/
sars/country/table2004_04_21/en/.
4. World Health Organization. Cumulative
number of confirmed human cases
for avian influenza A(H5N1) reported
to WHO, 2003-2020 [Internet] 2020
[cited 2020 April 1]. Available from:
https://www.who.int/influenza/human_
animal_interface/2020_01_20_tableH5N1.
pdf?ua=1.
5. World Health Organization. Chikungunya
[Internet] 2017 [cited 2020 April 14].
Available from: https://www.who.int/
en/news-room/fact-sheets/detail/
chikungunya.
6. Kelly H, Peck HA, Laurie KL, et al. The agespecific cumulative incidence of infection
with pandemic influenza H1N1 2009
was similar in various countries prior to
vaccination. PLoS One 2011;6(8):e21828.
doi:10.1371/journal.pone.0021828.
7. World Health Organization. MERS situation
update, January 2020 [Internet] 2020
[cited 2020 April 14]. Available from:
http://www.emro.who.int/pandemicepidemic-diseases/mers-cov/merssituation-update-january-2020.html.
8. World Health Organization. Ebola virus
disease [Internet] 2020 [cited 2020 April
10]. Available from: https://www.who.int/
en/news-room/fact-sheets/detail/ebolavirus-disease.
9. World Health Organization. Zika situation
report [Internet] 2017 [cited 2020 April
14]. Available from: https://www.who.
int/emergencies/zika-virus/situationreport/10-march-2017/en/.
10. Wo r l d o m e t e r s . i n f o . C O V I D - 1 9
Coronavirus pandemic 2020 [Internet]
2020 [cited 2020 June 1]. Available
from: https://www.worldometers.info/
coronavirus/#countries.
11. Morse SS. Factors in the emergence
of infectious diseases. Emerg Infect Dis
1995;1(1):7-15.
12. Woolhouse ME, Gowtage-Sequeria
S. Host range and emerging and
reemerging pathogens. Emerg Infect Dis
2005;11(12):1842-7.
13. Mukherjee S. Emerging infectious diseases:
epidemiological perspective. Indian J
Dermatol 2017;62(5):459-67.
14. Woolhouse M, Scott F, Hudson Z, et al.
Human viruses: discovery and emergence.
Philos Trans R Soc B 2012;367(1604):
2864-71.
15. Colson P, Richet H, Desnues C, et al. Pepper
mild mottle virus, a plant virus associated
with specific immune responses, fever,
abdominal pains, and pruritus in humans.
PLoS One 2010;5(4):e10041. doi: 10.1371/
journal.pone.0010041.
16. Lu R, Zhao X, Li J, et al. Genomic
characterization and epidemiology of
2019 novel coronavirus: implications for
virus origins and receptor binding. Lancet
2020;395(10224):565-74.
17. Enright MC, Robinson DA, Randle G, et al.
The evolutionary history of methicillinresistant Staphylococcus aureus (MRSA).
Proc Natl Acad Sci USA 2002;99(11):
7687-92.
18. Chang S, Sievert DM, Hageman JC, et
al. Infection with vancomycin-resistant
Staphylococcus aureus containing the
vanA resistance gene. N Engl J Med
2003;348(14):1342-7.
19. Peacock SJ, Paterson GK. Mechanisms of
methicillin resistance in Staphylococcus
aureus. Annu Rev Biochem 2015;84:577-601.
20. Gardete S, Tomasz A. Mechanisms of
vancomycin resistance in Staphylococcus
aureus. J Clin Invest 2014;124(7):2836-40.
21. Peck KM, Lauring AS. Complexities of viral
mutation rates. J Virol 2018;92(14):e01031-
17 doi: 10.1128/JVI.01031-17.
22. Garten RJ, Davis CT, Russell CA, et al.
Antigenic and genetic characteristics
of swine-origin 2009 A(H1N1) influenza
viruses circulating in humans. Science
2009;325(5937):197-201.
23. de Silva UC, Tanaka H, Nakamura S,
et al. A comprehensive analysis of
reassortment in influenza A virus. Biol
Open 2012;1(4):385-90.
24. Jean-Baptiste A, Michael EH. Virulence
evolution in emerging infectious diseases.
Evolution 2005;59(7):1406-12.
25. Schuffenecker I, Iteman I, Michault A, et al.
Genome microevolution of chikungunya
viruses causing the Indian Ocean outbreak.
PLoS Med 2006;3(7):e263. doi: 10.1371/
journal.pmed.0030263.
26. Tsetsarkin KA, Vanlandingham DL, McGee
CE, et al. A single mutation in chikungunya
virus affects vector specificity and epidemic
potential. PLoS Pathog 2007;3(12):e201.
doi: 10.1371/journal.ppat.0030201.
27. Hapuarachchi HC, Bandara KB, Sumanadasa
SD, et al. Re-emergence of chikungunya
virus in South-East Asia: virological
evidence from Sri Lanka and Singapore.
J Gen Virol 2010;91(Pt 4):1067-76.
28. Rianthavorn P, Prianantathavorn K,
Wuttirattanakowit N, et al. An outbreak
of chikungunya in southern Thailand
from 2008 to 2009 caused by African
strains with A226V mutation. Int J Infect
Dis 2010;14 Sppl 3:e161-5. doi: 10.1016/j.
ijid.2010.01.001.
29. Park YK, Park Y-S, Na KI, et al. Increased
tuberculosis burden due to demographic
transition in Korea from 2001 to 2010.
Tuberc Respir Dis 2013;74(3):104-10.
30. Davies PDO. Tuberculosis in the elderly.
Drugs Aging 1996;8(6):436-44.
31. Thomas TY, Rajagopalan S. Tuberculosis
and aging: a global health problem. Clin
Infect Dis 2001;33(7):1034-9.
32. Zuber PL, McKenna MT, Binkin NJ, et al.
Long-term risk of tuberculosis among
foreign-born persons in the United States.
JAMA 1997;278(4):304-7.
33. Jones KE, Patel NG, Levy MA, et al. Global
trends in emerging infectious diseases.
Nature 2008;451(7181):990-3.
34. Hui DS. Super-spreading events of
MERS-CoV infection. Lancet 2016;388
(10048):942-3.
35. Shen Z, Ning F, Zhou W, et al.
Superspreading SARS events, Beijing,
2003. Emerg Infect Dis 2004;10(2):256-60.
36. Michienzi SM, Burgos RM, Novak RM.
Mycobacterium conceptionense
pneumonitis in patient with HIV/AIDS.
Emerg Infect Dis 2019;25(10):1986-8.
37. Tobin-D’Angelo M, Oosmanally N,
Wilson SN, et al. Shigella bacteremia,
Georgia, USA, 2002-2012. Emerg Infect Dis
2020;26(1):122-4.
38. Wilson ME. Travel and the emergence
of infectious diseases. Emerg Infect Dis
1995;1(2):39-46.
39. Cherry JD. The chronology of the 2002-
2003 SARS mini pandemic. Paediatr Respir
Rev 2004;5(4):262-9.
40. Tatem AJ, Rogers DJ, Hay SI. Global
transport networks and infectious disease
spread. Adv Parasitol 2006;62:293-343.
41. Wilcox B, Ellis B. Forests and emerging
infectious diseases of humans. Unasylva
2006;57:11-8.
42. Bloomfield LSP, McIntosh TL, Lambin
EF. Habitat fragmentation, livelihood
behaviors, and contact between people
and nonhuman primates in Africa. Landsc
Ecol 2020;35(4):985-1000.
43. Olivero J, Fa JE, Real R, et al. Recent
loss of closed forests is associated with
Ebola virus disease outbreaks. Sci Rep
2017;7(1):14291.
44. Southgate VR. Schistosomiasis in the
Senegal River Basin: before and after
the construction of the dams at Diama,
Senegal and Manantali, Mali and future
prospects. J Helminthol 1997;71(2):
125-32.
45. Steinmann P, Keiser J, Bos R, et al.
Schistosomiasis and water resources
development: systematic review, metaanalysis, and estimates of people at risk.
Lancet Infect Dis 2006;6(7):411-25.
46. Sokolow SH, Jones IJ, Jocque M, et al.
Nearly 400 million people are at higher
risk of schistosomiasis because dams
block the migration of snail-eating river
prawns. Philos T R Soc B 2017;372(1722).
47. Caminade C, Kovats S, Rocklov J, et al.
Impact of climate change on global
malaria distribution. Proc Natl Acad Sci
USA 2014;111(9):3286-91.
48. Chretien JP, Anyamba A, Small J, et al.
Global climate anomalies and potential
infectious disease risks: 2014-2015.
PLoS Curr 2015;7. doi: 10.1371/currents.
outbreaks.95fbc4a8fb4695e049baabfc
2fc8289f.
49. Kovats RS, Bouma MJ, Hajat S, et al. El
Nino and health. Lancet 2003;362(9394):
1481-9.
50. Flahault A, de Castaneda RR, Bolon I.
Climate change and infectious diseases.
Public Health Rev 2016;37:21.
51. Phupat P, Sittisak S, Pimrat K, et al.
Epidemiological and serological study of
re-emerging diphtheria in Dansai District,
Loei Province, Thailand, June to October
2012. OSIR 2015;8(1):13-21.
52. Phadke VK, Bednarczyk RA, Salmon DA,
et al. Association between vaccine refusal
and vaccine-preventable diseases in the
United States: a review of measles and
pertussis. JAMA 2016;315(11):1149-58.
53. Wallin T, Holzschuh E, Kintner C. Notes
from the field: rubella infection in an
unvaccinated pregnant woman - Johnson
County, Kansas, December 2017. MMWR
2018;67(40):1132-3.
54. Akil L, Ahmad HA. The recent outbreaks
and reemergence of poliovirus in war and
conflict-affected areas. Int J Infect Dis
2016;49:40-6.
55. Mac Kenzie WR, Hoxie NJ, Proctor ME, et
al. A massive outbreak in Milwaukee of
cryptosporidium infection transmitted
through the public water supply. N Engl
J Med 1994;331(3):161-7.
56. Frank C, Werber D, Cramer JP, et al.
Epidemic profile of Shiga-toxin-producing
Escherichia coli O104:H4 outbreak in
Germany. N Engl J Med 2011;365(19):
1771-80.
57. Gelting R, Bliss K, Patrick M, et al. Water,
sanitation and hygiene in Haiti: past,
present, and future. Am J Trop Med Hyg
2013;89(4):665-70.
58. Chin CS, Sorenson J, Harris JB, et al. The
origin of the Haitian cholera outbreak
strain. N Engl J Med 2011;364(1):33-42.
59. Relman DA, Loutit JS, Schmidt TM, et al.
The agent of bacillary angiomatosis. An
approach to the identification of
uncultured pathogens. N Engl J Med
1990;323(23):1573-80.
60. Ablashi DV, Eastman HB, Owen CB, et al.
Frequent HHV-6 reactivation in multiple
sclerosis (MS) and chronic fatigue
syndrome (CFS) patients. J Clin Virol
2000;16(3):179-91.
61. Alvarez-Lafuente R, Garcia-Montojo M, De
las Heras V, et al. Clinical parameters and
HHV-6 active replication in relapsingremitting multiple sclerosis patients. J Clin
Virol 2006;37 (Sppl) 1:S24-6.
62. Pierce ES. Could Mycobacterium avium
subspecies paratuberculosis cause
Crohn’s disease, ulcerative colitis and
colorectal cancer? Infect Agents Cancer
2018;13:1.
63. Fashner J, Gitu AC. Diagnosis and treatment
of peptic ulcer disease and Helicobacter
pylori Infection. Am Fam Physician
2015;91(4):236-42.
64. Aslam B, Wang W, Arshad MI, et al.
Antibiotic resistance: a rundown of a
global crisis. Infect Drug Resist
2018;11:1645-58.
65. Manyi-Loh C, Mamphweli S, Meyer E, et
al. Antibiotic use in agriculture and its
consequential resistance in environmental
sources: potential public health
implications. Molecules 2018;23(4):795.
66. Marshall BM, Levy SB. Food animals and
antimicrobials: impacts on human health.
Clin Microbiol Rev 2011;24(4):718-33.
67. Engering A, Hogerwerf L, Slingenbergh J.
Pathogen-host-environment interplay and
disease emergence. Emerg Microbes Infect
2013;2(2):e5. doi: 10.1038/emi.2013.5.
68. Rezza G. Chikungunya is back in Italy:
2007–2017. J Travel Med 2018;25(1). doi:
10.1093/jtm/tay004.
69. Zhu N, Zhang D, Wang W, et al. A novel
coronavirus from patients with pneumonia
in China, 2019. N Engl J Med 2020;382(8):
727-33.
70. Li X, Giorgi EE, Marichannegowda MH, et
al. Emergence of SARS-CoV-2 through
recombination and strong purifying
selection. Sci Adv 2020:e9153. doi:
10.1101/2020.03.20.000885.
71. Zhou H, Chen X, Hu T, et al. A novel bat
coronavirus closely related to SARS-CoV-2
contains natural insertions at the S1/S2
cleavage site of the spike protein. Curr
Biol 2020;30(11):2196-203.
72. Allen T, Murray KA, Zambrana-Torrelio C,
et al. Global hotspots and correlates of
emerging zoonotic diseases. Nat Commun
2017;8(1):1124.
73. Li Q, Guan X, Wu P, et al. Early transmission
dynamics in Wuhan, China, of novel
coronavirus–infected pneumonia. N Engl
J Med 2020;382(13):1199-207.
74. World Health Organization. Modes of
transmission of virus causing COVID-19:
implications of IPC precaution
recommendations [Internet] 2020 [cited
2020 June 2]. Available from: https://
www.who.int/news-room/commentaries/
detail/modes-of-transmission-of-viruscausing-covid-19-implications-for-ipcprecaution-recommendations.
75. Al-Tawfiq JA, Rodriguez-Morales AJ. Superspreading events and contribution to
transmission of MERS, SARS, and COVID-19.
J Hosp Infect 2020;105:111-2.
76. Arons MM, Hatfield KM, Reddy SC, et al.
Presymptomatic SARS-CoV-2 Infections
and transmission in a skilled nursing
facility. N Engl J Med 2020;382(22):
2081-90.
77. Tian S, Hu N, Lou J, et al. Characteristics
of COVID-19 infection in Beijing. J Infect
2020;80(4):401-6.
78. World Health Organization. WHO directorgeneral’s opening remarks at the media
briefing on COVID-19 [Internet] 2020 [cited
2020 June 2]. Available from: https://
www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-atthe-media-briefing-on-covid-19-11-
march-2020.
79. World Health Organization. Strengthening
the health system response to COVID-19:
recommendations for the WHO European
Region [Internet] 2020 [cited 2020 June
2]. Available from: http://www.euro.who.
int/__data/assets/pdf_file/0003/436350/
strengthening-health-system-responseCOVID-19.pdf?ua=1.
Downloads
เผยแพร่แล้ว
2020-08-31
How to Cite
1.
ติ่งเพ็ชร พ. ปัจจัยส่งเสริมการเกิดโรคติดเชื้ออุบัติใหม่และโรคโควิด-19. J Med Health Sci [อินเทอร์เน็ต]. 31 สิงหาคม 2020 [อ้างถึง 6 เมษายน 2025];27(2):140-56. available at: https://he01.tci-thaijo.org/index.php/jmhs/article/view/244783
ฉบับ
บท
บทความวิชาการ
